73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
{{items.name}}
α-KG-dependent glycolysis activation by BCAT1 contributes to EGFR-TKI resistance in NSCLC
Oncology
α-KG-dependent glycolysis activation by BCAT1 contributes to EGFR-TKI resistance in NSCLC
November 28,2024
Latest Articles
Radiation/cisplatin combination established as standard of care for HPV+ oral cancer

Radiation/cisplatin combination established as standard of care for HPV+ oral cancer

byAmerican Society for Radiation OncologyCombinations of radiation and chemotherapy drugs have been shown to cure HPV-related head and neck cancer with a high success rate. A new phase III trial
Updated on: December 18,2023
Radiation/cisplatin combination established as standard of care for HPV+ oral cancer

Radiation/cisplatin combination established as standard of care for HPV+ oral cancer

byAmerican Society for Radiation OncologyCombinations of radiation and chemotherapy drugs have been shown to cure HPV-related head and neck cancer with a high success rate. A new phase III trial
Updated on:December 18,2023
Testing hundreds of therapeutics outside the body to predict their effectiveness against multiple myeloma

Testing hundreds of therapeutics outside the body to predict their effectiveness against multiple myeloma

by Peter Rüegg,ETH ZurichBone-marrow cells of a multiple myeloma patient. Red cells are healthy monocytes, green and yellow are plasma cells. Credit: Berend Snijder Lab / ETH ZurichMultiple myel
Updated on: February 20,2024
Testing hundreds of therapeutics outside the body to predict their effectiveness against multiple myeloma

Testing hundreds of therapeutics outside the body to predict their effectiveness against multiple myeloma

by Peter Rüegg,ETH ZurichBone-marrow cells of a multiple myeloma patient. Red cells are healthy monocytes, green and yellow are plasma cells. Credit: Berend Snijder Lab / ETH ZurichMultiple myel
Updated on:February 20,2024
Researchers develop new method of precisely targeting cancer lesions while protecting healthy tissues

Researchers develop new method of precisely targeting cancer lesions while protecting healthy tissues

by Kavli IPMUFigure 1. The radionuclide-encapsulated liposomes, including the focus of the study, a ligand called ethylenedicysteine (EC). Credit: Umeda et alA team of researchers has developed a new
Updated on: January 05,2024
Researchers develop new method of precisely targeting cancer lesions while protecting healthy tissues

Researchers develop new method of precisely targeting cancer lesions while protecting healthy tissues

by Kavli IPMUFigure 1. The radionuclide-encapsulated liposomes, including the focus of the study, a ligand called ethylenedicysteine (EC). Credit: Umeda et alA team of researchers has developed a new
Updated on:January 05,2024
Hodgkin lymphoma survivors show signs of dementia in early adulthood

Hodgkin lymphoma survivors show signs of dementia in early adulthood

by Leslie Orr,University of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainIn a new study, the majority of individuals treated as children for Hodgkin lymphoma who are now in their 30s
Updated on: December 25,2023
Hodgkin lymphoma survivors show signs of dementia in early adulthood

Hodgkin lymphoma survivors show signs of dementia in early adulthood

by Leslie Orr,University of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainIn a new study, the majority of individuals treated as children for Hodgkin lymphoma who are now in their 30s
Updated on:December 25,2023
Drug-resistant tuberculosis responds rapidly to bedaquiline-based second-line therapy

Drug-resistant tuberculosis responds rapidly to bedaquiline-based second-line therapy

by Weill Cornell Medical CollegeMycobacterium tuberculosis. Credit: United States Centers for Disease Control and PreventionPatients who have drug-resistant tuberculosis (TB) have a similar micro
Updated on: May 26,2024
Drug-resistant tuberculosis responds rapidly to bedaquiline-based second-line therapy

Drug-resistant tuberculosis responds rapidly to bedaquiline-based second-line therapy

by Weill Cornell Medical CollegeMycobacterium tuberculosis. Credit: United States Centers for Disease Control and PreventionPatients who have drug-resistant tuberculosis (TB) have a similar micro
Updated on:May 26,2024
High-dose, high-precision radiation therapy safe, effective for solitary kidney cancer patients with only one kidney

High-dose, high-precision radiation therapy safe, effective for solitary kidney cancer patients with only one kidney

byAmerican Society for Radiation OncologyTreatment of renal cell carcinoma with stereotactic radiation therapy is as safe and effective for patients with one kidney as it is for those who have t
Updated on: December 18,2023
High-dose, high-precision radiation therapy safe, effective for solitary kidney cancer patients with only one kidney

High-dose, high-precision radiation therapy safe, effective for solitary kidney cancer patients with only one kidney

byAmerican Society for Radiation OncologyTreatment of renal cell carcinoma with stereotactic radiation therapy is as safe and effective for patients with one kidney as it is for those who have t
Updated on:December 18,2023
Proposed lung cancer screening guideline could eliminate racial disparities, allow for early detection

Proposed lung cancer screening guideline could eliminate racial disparities, allow for early detection

by Liz Murphy,Massachusetts General HospitalDistribution of smoking duration (years), smoking intensity (cigarettes per day), and pack-year smoking history among SCCS participants diagnosed with
Updated on: August 27,2024
Proposed lung cancer screening guideline could eliminate racial disparities, allow for early detection

Proposed lung cancer screening guideline could eliminate racial disparities, allow for early detection

by Liz Murphy,Massachusetts General HospitalDistribution of smoking duration (years), smoking intensity (cigarettes per day), and pack-year smoking history among SCCS participants diagnosed with
Updated on:August 27,2024
FDA approves new treatment for advanced melanoma

FDA approves new treatment for advanced melanoma

by Robin FosterThe U.S. Food and Drug Administration has approved a novel treatment for advanced melanoma, the most deadly form of skin cancer.Amtagvi, made by Iovance Biotherapeutics Inc., becomes th
Updated on: March 22,2024
FDA approves new treatment for advanced melanoma

FDA approves new treatment for advanced melanoma

by Robin FosterThe U.S. Food and Drug Administration has approved a novel treatment for advanced melanoma, the most deadly form of skin cancer.Amtagvi, made by Iovance Biotherapeutics Inc., becomes th
Updated on:March 22,2024
A silent killer, liver cancer prompts race to improve organ replacements

A silent killer, liver cancer prompts race to improve organ replacements

by Anthony King,Horizon: The EU Research & Innovation MagazineBioprinter from Organtrans. Credit: © Gilles WederWith the only cure for liver cancer often being a transplantation, scientists
Updated on: December 22,2023
A silent killer, liver cancer prompts race to improve organ replacements

A silent killer, liver cancer prompts race to improve organ replacements

by Anthony King,Horizon: The EU Research & Innovation MagazineBioprinter from Organtrans. Credit: © Gilles WederWith the only cure for liver cancer often being a transplantation, scientists
Updated on:December 22,2023
More News
Categories
Allergy&Clinical immunology
Anesthesiology & Pain
Cardiovascular Diseases
Dermatology
Diabetes & Endocrinology
Emergency Medicine & Critical Care
ENT & HN
Family Medicine
Gastroenterology
General Surgery
Geriatrics
Hematology&Oncology
Infectious Diseases
Nephrology & Urology
Neurology
Nutrition
OB & GYN
Ophthalmology
Orthopedics & Sports medicine
Pediatrics
Plastic Surgery
Psychiatry & Mental Health
Public Health & Prevention
Pulmonology
Rheumatology
Stomatology
Sleep
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com